Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-25-018346
Filing Date
2025-05-12
Accepted
2025-05-12 13:58:04
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 4568
2 EXHIBIT A ef20048783_ex99-1.htm EX-99.1 4529
  Complete submission text file 0001140361-25-018346.txt   10912
Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

EIN.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SCHEDULE 13G/A

Mailing Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588
Business Address 6230 STONERIDGE MALL ROAD PLEASANTON CA 94588 (925) 401-7300
10x Genomics, Inc. (Subject) CIK: 0001770787 (see all company filings)

EIN.: 455614458 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91164 | Film No.: 25934081
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)